[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-469590-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-469590-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","aptamer-engineering-strategies-for-discovering-functional-nucleic-acids-for-next-generation-diagnostics-and-biosensing","Aptamer Engineering - Strategies for Discovering Functional Nucleic Acids for Next-Generation Diagnostics and Biosensing","","Aptamers are highly selective nucleic-acid ligands that address limitations of antibodies, but their routine adoption is constrained by discovery approaches that are slow and low-throughput. This review explains how the field has evolved from SELEX toward newer wet-lab and in-silico aptamer engineering methods to accelerate discovery and optimization. It summarizes recent applications of engineered aptamers, including target-binding assays and analytical nanomaterials, and extends to diagnostics and biosensing beyond the laboratory.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/aptamer-engineering-strategies-for-discovering-functional-nucleic-acids-for-next-generation-diagnostics-and-biosensing/469590/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/aptamer-engineering-strategies-for-discovering-functional-nucleic-acids-for-next-generation-diagnostics-and-biosensing/469590.png","ImageObject",300,407,{"name":42,"@type":43},"Danger Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-30",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What challenges limit the routine use of aptamers despite their selectivity?","Question",{"text":63,"@type":64},"Aptamer discovery and optimization have been limited by existing methods that remain relatively slow and low-throughput. In vivo use is also challenged by nucleases that rapidly degrade unmodified aptamers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is SELEX and why is it important in aptamer discovery?",{"text":68,"@type":64},"SELEX is described as the gold-standard method for aptamer discovery. It has played a pivotal role in advancing the field, even as newer approaches are sought for faster solutions.",{"name":70,"@type":61,"acceptedAnswer":71},"How does this review organize aptamer engineering strategies?",{"text":72,"@type":64},"It covers both wet-lab methods performed in vitro and dry-lab methods performed in silico. It also discusses applications of engineered aptamers in and beyond the laboratory.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},469590,1790893056,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":97,"preview_urls":147},962090769052,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","REVIEW  \n[www.advancedscience.com](www.advancedscience.com)  \nAptamer Engineering: Strategies for Discovering Functional Nucleic Acids for Next-Generation Diagnostics and Biosensing  \nJohn V. L. Nguyen, Ahlem Meziadi, Cyrill Brunner, Maureen McKeague, Lidija Malic,* and Maryam Tabrizian*  \nAptamers are highly selective nucleic acid ligands that overcome many challenges of antibodies, including structural instability and high production costs. The implementation of aptamers into routine research and commercial applications has advanced steadily, though it has been tempered by the limitations of existing discovery methods, which remain relatively slow and low-throughput. SELEX, the gold-standard method for aptamer discovery, has played a pivotal role in the ﬁeld. As the demand for faster and more tailored solutions grows, there is increasing recognition of the value of newer approaches that can expedite the discovery and optimization of aptamers for speciﬁc applications. This review discusses recent advances in the methods used for aptamer engineering, including both wet lab methods performed in vitro, and dry lab methods performed in silico. Applications of engineered aptamers described in recent literature and discuss new developments that could further lead to innovative new applications of aptamers for use both within and outside of the laboratory are discussed. Within the laboratory, these applications include (but are not limited to) target-binding assays and integration into analytical nanomaterials, and outside of the laboratory, diagnostics and biosensing, which will be discussed at length.  \nmotifs interact with proteins such as polymerases and transcription factors. However, aptamers are polymer sequences, typically single-stranded DNA or RNA, that fold into 3D structures and have the ability to bind to a range of molecules with high aﬃnity and speciﬁcity via intermolecular forces. Since their discovery,[2,3] the premise that aptamers could one day be applied to a magnitude of diﬀerent problems both within and outside of the laboratory has been a key motivation for further study of these biomolecules. While an occurrence of a naturally produced aptamercan be observed by the ligand-binding element of riboswitches,[4] the production of aptamers today is largely an in vitro process.  \nThe ability of aptamers to bind to speciﬁc targets has led to comparisons with antibodies. [5] Their typical size range of 20 to 100 nucleotides[6] means that they are smaller in size compared to antibodies, allowing for improved transport, tissue penetration,[7] and small particle  \n1. Introduction  \nNucleic acids (DNA and RNA), molecules which were classically only thought of as the medium for encoding genetic information,[1] have since been proven to possess an intrinsic ability to bind to other molecules. Indeed, many DNA or RNA  \nsensing. [8] Their nucleic acid composition makes them faster, easier, and less expensive to synthesize than peptides[7] and also more shelf-stable than antibodies. [9] Their screening process means that aptamers can be found for nonimmunogenic molecules and against toxins that would otherwise be lethal to animals during antibody production. [10] Their high  \nJ. V. L. Nguyen, A. Meziadi, L. Malic, M. Tabrizian Department of Biomedical Engineering  \nMcGill University  \n3775 University Street, Montreal, QC H3A 2B4, Canada  \nE-mail: [lidija.malic@cnrc-nrc.gc.ca](lidija.malic@cnrc-nrc.gc.ca); [maryam.tabrizian@mcgill.ca](maryam.tabrizian@mcgill.ca)  \nC. Brunner  \nBruker Switzerland AG  \nIndustriestrasse 26, Faellanden CH-8117, Switzerland  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202516852](https://doi.org/10.1002/advs.202516852)[ ](https://doi.org/10.1002/advs.202516852)© 2025 The Author(s). Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which pe","cbCaiewG0ginMhh6","https://ap.wps.com/l/cbCaiewG0ginMhh6","pdf",5813710,43,"English","# Introduction\n## Aptamers and their advantages over antibodies\n## Discovery methods and the role of SELEX\n## Engineering strategies: wet lab and in silico\n## Applications: assays, nanomaterials, diagnostics and biosensing","[{\"question\":\"What challenges limit the routine use of aptamers despite their selectivity?\",\"answer\":\"Aptamer discovery and optimization have been limited by existing methods that remain relatively slow and low-throughput. In vivo use is also challenged by nucleases that rapidly degrade unmodified aptamers.\"},{\"question\":\"What is SELEX and why is it important in aptamer discovery?\",\"answer\":\"SELEX is described as the gold-standard method for aptamer discovery. It has played a pivotal role in advancing the field, even as newer approaches are sought for faster solutions.\"},{\"question\":\"How does this review organize aptamer engineering strategies?\",\"answer\":\"It covers both wet-lab methods performed in vitro and dry-lab methods performed in silico. It also discusses applications of engineered aptamers in and beyond the laboratory.\"}]","Aptamer Engineering - Strategies for Discovering Functional Nucleic Acids for Next-Generation Diagnostics and Biosensing | PDF",1790775892,108,[148,152,156,160,164],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/e891eac87d67aec3264401dbaf0db24c.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/77b74a24281035cecb9e1abb76b59cf7.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/e19ee16e97e12516771201d22079bcb5.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/ce5ba079ffcb8242f8220d222a46c6ac.webp",980,1287,{"page_no":97,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/324ce8eae4a0a68481a225569239af6b.webp",979,1286]